Lee Biosolutions 125-10

Lab Reagents

Human IgG antibody Laboratories manufactures the lee biosolutions 125-10 reagents distributed by Genprice. The Lee Biosolutions 125-10 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Lee Biosolutions Ltd.. Other Lee products are available in stock. Specificity: Lee Category: Biosolutions Group: 125-10

125-10 information

KinaSorb™ 10

KE785-10 10 preps
EUR 461


A8694-10 10 mg
EUR 212
Description: AI-10-49 is a selective inhibitor of CBF? -SMMHC and RUNX1 interaction with a FRET IC50 value of 260nM. AI-10-49 restores RUNX1 transcriptional activity, displays favorable pharmacokinetics, and delays leukemia progression in mice.

Keratin 10 antibody

10-2541 250 ug
EUR 492
Description: Mouse monoclonal Keratin 10 antibody

LB*Booster™, Powder 100

125 100 ml
EUR 86

GFP Antibody, 10 uL

P601-10 - Ask for price

Ro 10-5824 dihydrochloride

B7019-10 10 mg
EUR 267


B1262-10 10 mg
EUR 303
Description: HG-10-102-01 is a potent and selective inhibitor of leucine-rich repeat kinase 2 (LRRK2) with the IC50 values of 20.3nM and 3.2nM for wild type LRRK2 and LRRK2 [G1019S], respectively [1].

Individual Reaction Mix 10

G065-10 200 reactions
EUR 167

C-10, murine recombinant

EUR 256

IL-10, human recombinant

EUR 245

IL-10, murine recombinant

EUR 245

IL-10, rat recombinant

EUR 300


7078D-10 25/pk
EUR 259
Description: Disposable Pipets; Disposable Pipets, Serological, Misc

[bAla8]-Neurokinin A(4-10)

B6813-10 10 mg
EUR 1479

Beta-Lipotropin (1-10), porcine

A1014-10 10 mg
EUR 166
Description: Morphine-like substances exist in brain or the pituitary of various species. Beta-lipotropin (beta-LPH) was found to contain within its C-terminal sequence the primary structure of these peptides.

Amyloid ?-Peptide (10-20) (human)

A1038-10 10 mg
EUR 630
Description: The amyloid ?-peptide (A?) has a central role in initiating neurodegeneration in Alzheimer disease (AD) 1. It is widely believed to be an incidental catabolic byproduct of the amyloid ? protein precursor (APP) with no normal physiological function.

Amyloid ?-peptide (10-35), amide

A1102-10 10 mg
EUR 456
Description: Amyloid ?-protein (10-35) was used as a trunCated peptide model for the full-length amyloid ?-proteins (1-40) and (1-42) in high-resolution structural studies. In contrast to the full-length amyloid ?-proteins, amyloid ?-protein (10-35) allowed the contro